0001062993-24-003170.txt : 20240214
0001062993-24-003170.hdr.sgml : 20240214
20240214161534
ACCESSION NUMBER: 0001062993-24-003170
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240212
FILED AS OF DATE: 20240214
DATE AS OF CHANGE: 20240214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tupper Colleen
CENTRAL INDEX KEY: 0001862082
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37372
FILM NUMBER: 24638415
MAIL ADDRESS:
STREET 1: C/O COLLEGIUM PHARMACEUTICAL, INC.
STREET 2: 100 TECHNOLOGY CENTER DRIVE
CITY: STOUGHTON
STATE: MA
ZIP: 02072
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COLLEGIUM PHARMACEUTICAL, INC
CENTRAL INDEX KEY: 0001267565
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: VA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 TECHNOLOGY CENTER DRIVE
CITY: STOUGHTON
STATE: MA
ZIP: 02072
BUSINESS PHONE: 781-713-3699
MAIL ADDRESS:
STREET 1: 100 TECHNOLOGY CENTER DRIVE
CITY: STOUGHTON
STATE: MA
ZIP: 02072
FORMER COMPANY:
FORMER CONFORMED NAME: COLLEGIUM PHARMACEUTICAL INC
DATE OF NAME CHANGE: 20031020
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2024-02-12
0001267565
COLLEGIUM PHARMACEUTICAL, INC
COLL
0001862082
Tupper Colleen
C/O COLLEGIUM PHARMACEUTICAL, INC.
100 TECHNOLOGY CENTER DRIVE
STOUGHTON
MA
02072
0
1
0
0
EVP & Chief Financial Officer
0
Common Stock
2024-02-12
4
A
0
40600
0
A
146020
D
Common Stock
2024-02-12
4
A
0
30856
0
A
176876
D
Common Stock
2024-02-12
4
F
0
16868
33.70
D
160008
D
Common Stock
2024-02-12
4
F
0
9453
33.70
D
150555
D
Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2025, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.
Effective February 12, 2024, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 30,856 performance share units ("PSUs") granted in the Issuer's three prior fiscal years.
Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs.
Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs.
/s/ Colleen Tupper
2024-02-14